AI-assisted cancer diagnosis co Nucleai raises $5m

Nucleai, which is developing an artificial intelligence system for computerized analysis of biopsies, has raised $5 million in a round led by Vertex Ventures and Grove Ventures, with participation by private investors Brian Cooper (founder of Retalix) and Nir Kalkstein (co-founder of Final and Medial Early …
Read more: AI-assisted cancer diagnosis co Nucleai raises m

Please Login to Comment.